Brain biochemistry in Duchenne muscular dystrophy: A 1H magnetic resonance and neuropsychological study

Journal of the Neurological Sciences

Volumn 160, Issue 2, 1998, Pages 148-157

  Rae, Caroline ^a,c   Scott, Richard B ^b   Thompson, Campbell H ^a,c   Dixon, Ruth M ^a   Dumughn, Ishbel ^b   Kemp, Graham J ^a   Male, Alison ^d   Pike, Michael ^a   Styles, Peter ^a   Radda, George K ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Cerebellum; Choline containing compounds; Duchenne muscular dystrophy; Intellectual impairment; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE;

ARTICLE; BRAIN METABOLISM; CEREBELLUM; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; INTELLIGENCE QUOTIENT; MUSCULAR DYSTROPHY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY;

AGE FACTORS; ASPARTIC ACID; BRAIN; CEREBELLUM; CHILD; CHOLINE; COGNITION; CREATINE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCULAR DYSTROPHIES; NEUROPSYCHOLOGICAL TESTS;

EID: 0032497562     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00190-7     Document Type: Article

References (73)

1. Ahn A.H., Kunkel L.M. The structural and functional diversity of dystrophin. Nature Genet. 3:1993;283-291.
2. Allen G.I., Tsukuhara N. Cerebrocerebellar communication systems. Physiol Rev. 54:1974;957-1008.
3. Al-Qudah A.A., Kobayashi J., Chuang S., Dennis M., Ray P. Etiology of intellectual impairment in Duchenne muscular dystrophy. Pediatr Neurol. 6:1990;57-59.
4. Anderson S.W., Routh D.K., Ionasescu V.V. Serial position memory of boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 30:1988;328-333.
5. Andre P., Pompeiano O., White S.R. Activation of muscarinic receptors induces a long-lasting enhancement of Purkinje cell responses to glutamate. Brain Res. 617:1993;28-36.
6. Bates T.E., Strangward M., Keelan J., Davey G.P., Munro P.M., Clarke J.B. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport. 7:1995;1397-1400.
7. Barker P.B., Breiter S.N., Soher B.J.et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med. 32:1994;157-163.
8. Billard C., Gillet P., Signoret J.L.et al. Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy. Neuromusc Disord. 2:1992;371-378.
9. Botez T., Botez M.I. Unilateral and bilateral cerebellar lesions: neuropsychological performances. Neurology. 42:1992;529.
10. Botez M.I. The neuropsychology of the cerebellum: an emerging concept. Arch Neurol, Letters to the Editor. 49:1992;1229-1230.
11. Bracke-Tolkmitt R., Linden A., Canavan A.G.M.et al. The cerebellum contributes to mental skills. Behav Neurosci. 103:1989;442-446.
12. Bresolin N., Castelli E., Comi G.P.et al. Cognitive impairment in Duchenne muscular dystrophy. Neuromusc Disord. 4:1994;113-128.
13. Bullfield G., Siller W.G., Wight P.A.L., Moore K.J. X Chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
14. Bushby K.M.D., Appleton R., Anderson L.V.B., Welch J.L., Kelly P., Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 37:1995;260-269.
15. Chelly J., Hamard G., Koulakoff A., Kaplan J.C., Kahn A., Berwald-Netter Y. Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature. 344:1990;64-65.
16. Court J.A., Perry E.K., Johnson M.et al. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Dev Brain Res. 74:1993;73-82.
17. Ciesielski K.T., Yanofsky R., Ludwig R.N.et al. Hypoplasia of the cerebellar vermis and cognitive deficits in survivors of childhood leukemia. Arch Neurol. 51:1994;985-993.
18. Decety J., Ingvar D.H. Brain structures participating in mental stimulation of motor behaviour: a neuropsychological interpretation. Acta Psychol (Amst). 73:1990;13-34.
19. Dorman C., DesNoyers Hurley A., D'Avignon J. Language and learning disorders of older boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 30:1988;316-327.
20. Dubowitz V. Involvement of the nervous system in muscular dystrophies in man. Ann New York Acad Sci, 1979;431-9.
21. Eccles J. Cerebellar function and the control of movement. In: Rose FC, editor. Physiological aspects of clinical neurology. Oxford: Blackwell, 1977:157-78.
22. Emery AEH. Duchenne Muscular Dystrophy. Rev ed. Oxford: Oxford Medical Publications, Oxford University Press, 1988.
23. Ervasti J.M., Campbell K.P. Membrane organisation of the dystrophinglycoprotein complex. Cell. 66:1991;1121-1131.
24. Ervasti J.M., Ohlendieck K., Kahl S.D., Gayer M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:1990;315-319.
25. Fiez J.A., Petersen S.E., Cheney M.K., Raichle M.E. Impaired non-motor learning and error detection associated with cerebellar damage. A single case study. Brain. 115:1992;155-178.
26. Fong T.M., McNamee M.G. Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry. 25:1986;830-840.
27. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localised high resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 9:1989;79-93.
28. Gadian D.G., Isaacs E.B., Cross J.H.et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology. 46:1996;974-977.
29. Gee S.H., Montanaro F., Lindenbaum M.H., Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 77:1994;675-686.
30. Gill S.S., Thomas D.G.T., van Bruggen N.et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr. 14:1990;497-504.
31. Gorecki D., Geng Y., Thomas K., Hunt S.P., Barnard E.A., Barnard P.J. Expression of the dystrophin gene in mouse and rat brain. Neuroreport. 2:1991;773-776.
32. Hardiman O. Dystrophin deficiency, altered cell signalling and fibre hypertrophy. Neuromusc Disord. 4:1994;305-315.
33. Hossack J.A., Sharpe V.J., Rose A.H. Stability of the plasma membrane in Saccharomyces cerevisiae enriched with phosphatidylcholine or phosphatidylethanolamine. J Bacteriol. 129:1977;1144-1147.
34. Huard J., Côté P.-Y., Parent A., Bouchard J.P., Tremblay J.P. Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions. Neurosci Lett. 141:1992;181-186.
35. Ivry R.B., Keele S.W., Diener H.C. Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res. 73:1988;167-180.
36. Jagadha V., Becker L.E. Brain morphology in Duchenne muscular dystrophy: a golgi study. Pediatr Neurol. 4:1988;87-92.
37. Jasmin B.J., Cartaud A., Ludosky M.A., Changeux J.P., Cartaud J. Asymmetric distribution of dystrophin in developing and adult Torpedo marmorata electrocyte: evidence for its association with the acetylcholine receptor rich membrane. Proc Natl Acad Sci USA. 87:1990;3938-3941.
38. Kakulas BA, Jakobsen PF. Brain morphology in Duchenne muscular dystrophy (DMD) Proc. Xth International Congress of Neuropathology, Stockholm, 1986.
39. Kato T, Nishini M, Matushita K, Hon E, Akaboshi S, Iwasaki A, Takashimi S. (Abstract) Characteristic cerebral H-NMR spectroscopy in congenital myopathy. Proc Soc Magn Reson, 3rd meeting, Nice, France, 1995:1842.
40. Kim T.-W., Wu K., Black I.B. Deficiency of brain synaptic dystrophin in human Duchenne muscular dystrophy. Annal Neurol. 38:1995;446-449.
41. Leiner H.C., Leiner A.L., Dow R.S. Cerebro-cerebellar learning loops in apes and humans. Ital J Neurol Sci. 8:1987;425-436.
42. Leiner H.C., Leiner A.L., Dow R.S. The human cerebro-cerebellar system: its computing, cognitive, and language skills. Behav Brain Res. 44:1991;113-128.
43. Leiner H.C., Leiner A.L., Dow R.S. Cognitive and language function of the human cerebellum. Trends Neurol Sci. 16:1993;444-447.
44. Lidov H.G.W., Byers T.J., Watkins S.G., Kunkel L.M. Localisation of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 348:1990;725-728.
45. Lidov H.G.W., Byers T.J., Kunkel L.M. The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. J Neurosci. 54:1993;167-187.
46. Martin P.R., Gibbs S.J., Nimmerrichter A.A., Riddle W.R., Welch L.W., Willcott M.R. Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res. 19:1995;1078-1082.
47. MacKay S., Meyerhoff D.J., Constans J.M., Norman D., Fein G., Weiner M.W. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol. 53:1996;167-174.
48. Menke A., Jochusch H. Extent of shock-induced membrane leakage in human and mouse myotubules depends on dystrophin. J Cell Sci. 108:1995;727-733.
49. van Mier H., Tempel L.W., Perlmutter J.S., Raichle M.E., Petersen S.E. Generalization of practice-related effects in motor learning using the dominant and non-dominant hand measured by PET [abstract]. Soc Neruosci Abstr. 21:1995;1441.
50. Miller B.L., Chang L., Booth R.et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 58:1996;1929-1935.
51. Minetti C., Tanji K., Gasparo Rippa P., Morreale G., Cordone G., Bonilla E. Abnormalities in the expression of β-spectrin in Duchenne muscular dystrophy. Neurology. 44:1994;1149-1153.
52. Mount H.T.J., Dreyfus C.F., Black I.B. Muscarinic stimulation promotes cultured Purkinje cell survival: a role for acetyicholine in cerebellar development? J Neurochem. 63:1994;2065-2073.
53. Muntoni F., Mateddu A., Serra G. Passive avoidance deficit in the mdx mouse. Neuromusc Disord. 1:1991;121-123.
54. Pantano P., Baron J.C., Samson Y., Bousser M.G., Derouesne C., Comar D. Crossed cerebellar diaschisis: further studies. Brain. 109:1986;677-694.
55. Petersen S.E., Fox P.T., Posner M.I., Mintun M., Raichle M.E. Positron emission tomographic studies of the cortical anatomy of single-word processing. J Cogn Neurosci. 1:1989;153-170.
56. Roland P.E., Eriksson L., Widen L., Stone-Elander S. Changes in regional cerebral oxidative metabolism induced by tactile learning and recognition in man. Eur J Neurosci. 1:1989;3-18.
57. Rosman N.P. The cerebral defect and myopathy in Duchenne muscular dystrophy. Neurology. 20:1970;329-335.
58. Schmahmann J.D. An emerging concept: The cerebellar contribution to higher function. Arch Neurol. 48:1991;1178-1187.
59. Septien L., Gras P., Borsotti J.P., Giroud M., Nivelon J.L., Dumas R. Mental development in Duchenne Muscular Dystrophy. Correlation of data of the brain scanner (French). Pediatrie. 46(12):1991;817-819.
60. Shaw J.M., Henry J.E., Shaw K.V., Konigsberg I.R. Order measurements in plasma membranes from Duchenne dystrophy fibroblasts. Biochem Biophys Acta. 733:1983;1-14.
61. Sollee N.D., Latham E.E., Kindlon D.J., Bresnan M.J. Neuropsychological impairment in Duchenne muscular dystrophy. J Clin Exp Neuropsychol. 7:1985;486-496.
62. 31P magnetic resonance spectroscopy and neuropsychological study. Lancet. 345:1995;1260-1264.
63. Tracey I., Dunn J.F., Radda G.K. Brain metabolism is abnormal in the mdx mouse model of Duchenne muscular dystrophy. Brain. 119:1996;1039-1044.
64. Tracey I., Dunn J.F., Parkes H.G., Radda G.K. An in vivo and in vitro 1H-magnetic resonance spectroscopy study of mdx mouse brain: abnormal development or neural necrosis? J Neurol Sci. 141:1996;13-18.
65. Tracey T., Carr C.A., Guimares A.R., Worth J.L., Navia B.A., Gonzales R.G. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology. 46:1996;783-788.
66. Tucek S. Problems in the organisation and control of acetylcholine synthesis in brain neurones. Prog Biophys Molec Biol. 44:1984;1-46.
67. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 13:1993;981-989.
68. Vaillend C., Rendon A., Misslin R., Ungerer A. Influence of dystrophin-gene mutation on mdx mouse behaviour. I. Retention deficits at lang delays in spontaneous alternation and bar-pressing tasks. Behav Genet. 25:1995;569-579.
69. Wallesch C.-W., Horn A. Long-term effects of cerebellar pathology on cognitive functions. Brain Cogn. 14:1990;19-25.
70. Whelan T.B. Neuropsychological performance of children with Duchenne muscular dystrophy and spinal muscle atrophy. Dev Med Child Neurol. 29:1987;212-220.
71. Yoshioka M., Okuno T., Honda Y., Nakano Y. Central nervous system involvement in progressive muscular dystrophy. Arch Dis Child. 55:1980;589-594.
72. Zellweger H., Niedermeyer E. Central nervous manifestations in childhood muscular dystrophy (CMD). Psychometric and electroencephalographic findings. Ann Paediatr. 205:1965;25-42.
73. Karagan. Intellectual functioning in Duchenne muscular dystrophy. J Clin Exp Neuropsychol 1979; 86: 250-9.